Share on StockTwits

POZEN (NASDAQ:POZN) shares rose 8% on Friday after the company announced better than expected quarterly earnings, ARN reports. The company traded as high as $8.12 and last traded at $8.06, with a volume of 245,039 shares. The stock had previously closed at $7.46.

The company reported $0.09 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.07 by $0.02. The company had revenue of $7.40 million for the quarter, compared to the consensus estimate of $7.10 million. During the same quarter in the prior year, the company posted ($0.13) earnings per share. The company’s quarterly revenue was up 335.3% on a year-over-year basis.

A number of research firms have recently commented on POZN. Analysts at Ascendiant Capital Markets upgraded shares of POZEN from a “hold” rating to a “buy” rating in a research note on Friday. They now have a $10.00 price target on the stock. Analysts at TheStreet upgraded shares of POZEN from a “sell” rating to a “hold” rating in a research note on Monday, May 12th.

In other POZEN news, CEO John R. Plachetka unloaded 50,000 shares of POZEN stock on the open market in a transaction dated Wednesday, July 30th. The shares were sold at an average price of $7.34, for a total value of $367,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

The stock’s 50-day moving average is $8.22 and its 200-day moving average is $8.34. The company’s market cap is $249.3 million.

POZEN Inc (NASDAQ:POZN), is a pharmaceutical company focused on transforming medicine.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.